Showing results (811-820 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|November 22, 2023
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγAlice Newey, Lu Yu, Louise J Barber, et al.Cancer Research Communications|November 29, 2023
Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast CancerVikram Malhi, Priya Agarwal, Mary R Gates, et al.Cancer Research Communications|November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 ParticipantsShadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.Cancer Research Communications|January 10, 2024
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read SequencingChien-Wei Wang, Simon D Weaver, Nicha Boonpattrawong, et al.Cancer Research Communications|January 12, 2024
The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent MannerJoseph Mazar, Jeanne K Brooks, Matthew Peloquin, et al.Cancer Research Communications|December 26, 2023
Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck CancersEmma L Saulters, Paul T Kennedy, Rachel J Carter, et al.Cancer Research Communications|March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin TreatmentGiorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.Cancer Research Communications|March 5, 2024
Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian CancerShama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.Cancer Research Communications|February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCMari Nakazawa, Guilherme Harada, Paola Ghanem, et al.Cancer Research Communications|January 24, 2024
EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell CarcinomasTanner J DuCote, Xiulong Song, Kassandra J Naughton, et al.Pageof 102